DJ Moderna Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. $(MRNA)$ slipped 5.89% to $38.36 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 3.56% to 19,392.69 and Dow Jones Industrial Average falling 2.58% to 42,326.87.
This was the stock's second consecutive day of losses.
Moderna Inc. closed $132.11 below its 52-week high ($170.47), which the company reached on May 24th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.13% to $144.75 and Pfizer Inc. $(PFE)$ fell 2.04% to $25.89.
Trading volume (8.5 M) eclipsed its 50-day average volume of 7.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 18, 2024 16:32 ET (21:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments